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To the Editor:
In a recent issue of The Journal of Experi-
mental Medicine, Thomas Rothstein and 
colleagues, a group with long-standing 
expertise in the field of mouse B1 cells, 
reported the description of a B1 B cell 
subset  in  human  blood,  a  population 
that has thus far eluded identification 
(Griffin et al., 2011).
Mouse B1 cells are the main con-
stituents of the B lymphocyte pool in 
pleural  and  peritoneal  cavities,  and 
are  characterized  as  CD5
+  and/or 
CD11b
+  cells  (Hardy,  2006;  Baum-
garth, 2011). However, CD5, which 
was initially identified on chronic lym-
phocytic leukemia tumors (Boumsell 
et al., 1978), is not a B1 marker in 
humans. Human CD5 marks imma-
ture/transitional B cells in bone mar-
row, blood, and spleen (Sims et al., 
2005;  Cuss  et  al.,  2006),  as  well  as   
in T cells. Mouse B1 cells are also de-
scribed  as  IgM
highIgD
lowCD43
+.  The 
function of CD43 in B1 cells is un-
known,  and  it  is  also  expressed  by   
T lymphocytes, B cell precursors, and 
plasma cells.
Griffin  et  al.  (2011)  described  a 
CD20
+CD27
+CD43
+CD70
  subset 
present  in  adult  and  human  cord 
blood  with  functional  characteristics 
that they describe as typical B1 cell 
attributes: spontaneous IgM secretion, 
constitutive BCR signaling, and abil-
ity to drive allogeneic T cell prolifer-
ation. It should be noted that this last 
feature  has  been  shown  to  be  dis-
played by switched memory B cells in 
humans,  likely  because  of  the  high 
expression of CD80 and/or CD86 on 
these  cells  (Liu  et  al.,  1995;  Good   
et al., 2009).
A striking point of the observations 
of Griffin et al. (2011) was their quan-
titative  aspect.  Despite  considerable 
variations  between  individual  blood 
donors, the proportion of CD43
+ cells 
among  CD27
+  B  cells  averaged  40–
50% in adults, with a higher frequency 
in young individuals, and a lower fre-
quency  in  the  elderly.  We  find  this 
puzzling, as these quantitative figures 
closely match the frequency of mar-
ginal  zone–like  (or  IgM  memory)  B 
cells (Weill et al., 2009), with the dif-
ference being that marginal zone–like 
B  cells  are  IgD
int  whereas  CD43
+  B 
cells are mainly IgD
high (Griffin et al., 
2011). Therefore, we analyzed to what 
extent  these  two  populations  may 
superimpose.
CD43
+ B cells appear as large cells 
that require a wide lymphocyte gate 
to be detected. In so doing, the risk of 
inclusion of cell doublets in the analy-
sis/isolation is high. Usually, specific 
selective  criteria  on  the  cell  flow 
(FSC-W, SSC-W) are applied to re-
move  doublets,  unless  the  morpho-
logical  characteristics  of  the  cell 
population  justify  such  an  omission. 
In  such  cases,  careful  controls  are   
obviously required to avoid the con-
fusion  between  cell  doublets  and 
large cells.
We added anti-CD3 antibodies to 
the staining reaction, as T cells are the 
major  lymphocyte  subset  in  human 
blood compared with B cells (95:5). A 
large fraction of CD20
+CD27
+CD43
+ 
cells stained positive for CD3 (Fig. 1 
A).  We  believe  that  these 
CD20
+CD27
+CD43
+CD3
+  cells  are 
doublets involving T cells that account 
for the CD43 and CD27 labeling, and 
(mainly) naive B cells that account for 
the  IgD
high  phenotype  (unpublished 
data).  Pre-enrichment  of  peripheral 
blood B cells through CD19
+ selection 
strongly  reduced  the  proportion  of 
CD20
+CD27
+CD43
+ cells (Fig. 1 A).
Gating  on  CD20
+  cells  excluded 
plasma  cells,  identified  as 
CD43
++CD27
++CD38
++. The remain-
ing  CD20
+CD3
CD27
+CD43
+  cells 
accounted for 2–3% of the total B cell 
pool (2.2% for adult samples, 2.8% for 
child samples; Fig. 1, B and C). These 
cells  harbored  either  an  IgD
+  or  an 
IgD
 phenotype and a somewhat het-
erogeneous CD38 intensity (Fig. 1 B). 
Interestingly, the IgD
+ over IgD
 ratio 
among CD43
+ cells varied with age; 
IgD
+ cells dominated in children <5 yr, 
and  IgD
  cells  dominated  in  adults 
(Fig. 1 D). IgD
 cells include cells ex-
pressing IgG or IgA, as well as a mi-
nority of IgM-only cells (unpublished 
data). The presence of CD20
+CD43
+ 
cells displaying IgD, IgG, or IgA makes 
their possible B1 equivalence a more 
complex issue, even though B1 cells 
can give rise to IgA-producing plasma 
cells  in  the  lamina  propria  (Suzuki   
et al., 2010).
We  therefore  propose  that  the 
quantitative  variations  observed 
when counting CD43
+ B cells may 
be  largely  contributed  by  staining 
artifacts.  The  potential  presence  of 
doublet events in the CD20
+CD43
+ 
population analyzed by Griffin et al. 
(2011)  obviously  questions  the  in 
vitro  functional  characteristics  de-
scribed  for  this  putative  B1  subset. 
Whether  CD20
+CD43
+CD27
+IgD
+ 
or IgD
 B cells are activated cells on 
their way to plasma cell differentia-
tion or a new innatelike subset with 
B1  functional  features  remains  to   
be seen.
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Figure 1.  CD3, CD43, CD38 and IgD expression on human CD20
+CD27
+ PMBCs. (A) Human PM-
BCs were analyzed within a large lymphoid gate. The right dot plot represents cells after enrichment by 
CD19 microbeads (Miltenyi Biotec), whereas the left dot plot represents total PMBCs. The flow cytometric 
analysis shown was performed at a flow rate of <5,000 events per second. The data shown here for an 
adult are representative of eight adult blood samples analyzed in four separate experiments. (B) Represen-
tative analysis of an adult blood sample. PBMCs were analyzed within a large lymphoid gate, with dou-
blets excluded by SSC-W criteria. Cells were further gated as CD3
CD20
+ for analysis of CD27 and CD43 
expression. The small top right gate in the dot plot indicates plasmablasts that are excluded from the cell 
estimates. The histograms show the expression of IgD and CD38 on the CD43
+CD27
+ population. (C) Blood 
samples from 6 children (3–6.5 yr old) and 8 adults were analyzed as in B. The proportion of CD43
+CD27
+ 
cells among CD3
CD20
+ B cells (expressed either as percentage of total B cells or of CD27
+ B cells) is indi-
cated. Each bar represents the results obtained for one individual. (D) The relative distribution of IgD
+ and 
IgD
 B cells among the CD27
+CD43
+ B cell population is shown in bar graphs, each bar representing the 
results obtained for one individual. The following antibodies were used: CD20 (APC-H7, clone 2H7), CD43 
(FITC, clone 1G10), CD3 (PE, clone UCHT1), and CD27 (APC, clone M-T271) from BD; CD38 (PerCp-Cy5.5, 
clone HIT2) and IgD (PE-Cy7, clone IAG-2) from BioLegend. Flow cytometry analysis was performed on a 
FACSCanto II apparatus with FACSDiva software.
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To the Editor:
We recently read with great interest an 
article  in  The  Journal  of  Experimental 
Medicine from the laboratory of Thomas 
Rothstein (Griffin et al., 2011). This 
paper described a new B cell popula-
tion present in human cord blood and 
adult  peripheral  blood  that  displays 
functional  characteristics  shared  with 
mouse B1 cells.
In  contrast  to  B2  cells,  B1  cells 
spontaneously produce IgM and are an 
important source of natural antibodies 
in the absence of antigen stimulation in 
mouse (Hayakawa et al., 1984; Sidman 
et al., 1986). Human B1 cells were de-
fined based on coexpression of CD43 
and CD27 (Griffin et al., 2011). In ad-
dition, human B1 cells were found to 
express  CD20  and  lack  expression  of 
CD69  and  CD70.  Notably,  CD43  is 
also expressed on mouse B1 cells (Wells 
et al., 1994), as well as on human bone 
marrow  B  cell  precursors  and  plasma 
cells (MacMichael et al., 1987; Wikén 
et al., 1988), whereas CD27 is generally 
regarded as a marker for memory B cells 
in  humans  (Agematsu  et  al.,  1997; 
Tangye  et  al.,  1998).  Furthermore, 
CD27 and CD43 are coexpressed on 
the majority of blood T cells and plasma 
cells (MacMichael et al., 1987).
To gain further insight into the na-
ture of CD27
+CD43
+ B1 cells in hu-
mans, we developed a flow cytometric 
strategy  to  discriminate  between 
CD27
+CD43
+  B  cells  and  CD27
+ 
memory  B  cells  in  human  blood 
(Berkowska et al., 2011). Like Griffin 
et al. (2011), we systematically identi-
fied a CD27
+CD43
+ subset within the 
CD19
+ or CD20
+ B cell population in 
neonatal cord blood (n = 4 samples), 
in the peripheral blood of children and 
adults (n = 27 samples), and in child-
hood tonsils (n = 7 samples; Fig. 1, A–
C). Their frequencies ranged from 1 to 
25.5% of total CD19
+ or CD20
+ cells 
in blood (Fig. 1 D), and from 0.3 to 
3.7% of CD19
+ cells in childhood tonsil 
(unpublished data).
In contrast to most B lymphocytes, 
which  are  CD43
,  most  T  lympho-
cytes and plasma cells are CD43
+. To 
ensure that all identified CD43
+CD27
+ 
events constituted B lymphocytes, we 
further  analyzed  the  CD27
+CD43
+ 
population. A substantial fraction (0.1–
24%)  of  CD19
+CD27
+CD43
+  events 
was highly positive for CD3 and dimly 
positive for CD19. Analysis of CD19 
versus CD3 expression suggested that 
these  cells  were  T  lymphocytes  that 
were incorrectly included in the CD19
+ 
gate,  and  accounted  for  most  CD5
+ 
events in the gate (Fig. 1, A–C). Of the 
remaining  CD3
CD27
+CD43
+  cells, 
the majority showed high expression of 
CD38  (0.1–4.6%  of  CD19
+).  Coex-
pression  of  CD27  and  high  levels  of 
CD38 is typically seen on plasma cells, 
as well as on germinal center cells and 
plasma cells in tonsil (Klein et al., 2003; 
van  Zelm  et  al.,  2007;  Perez-Andres   
et al., 2010).
The nature of circulating CD27
+CD43
+ B cells
Figure 1.  Flow cytometric analysis of CD19
+CD27
+CD43
+ cells in human neonatal cord 
blood, peripheral blood, and tonsil samples. (A–C) CD27
+CD43
+ cells (red) were defined within 
CD19
+ lymphocytes (blue; left plots). Where illustrative, the CD19
 lymphocytes (T cells and NK cells) 
are shown in yellow. Samples were also stained with anti-CD3, anti-CD5, and anti-CD38 as indicated. 
The right plots only display CD19
+CD3
 events. Data are representative of 4 cord blood, 27 blood, 
and 7 tonsil samples. (D) Frequencies of CD27
+CD43
+ cells among CD19
+ cells in neonatal cord blood 
and peripheral blood samples from individual children and adults of indicated ages. The relative con-
tributions of CD3
+ T cells, CD3
CD38
hi plasma cells, and CD3
CD38
low B lymphocytes are indicated 
for each individual. (E) Frequencies of CD43
+, CD43
IgM
+, and CD43
-IgM
 cells among 
CD19
+CD27
+CD3
CD38
low cells within the blood of healthy adults. Individual frequencies are shown 
in gray and the median is indicated with a red bar. IgM expression was detected with a monoclonal 
IgM-HorizonV450 antibody (clone G20-127).2566
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Only  a  minority  of  the  CD19
+ 
CD27
+CD43
+  events  appeared  to 
be  true  B  lymphocytes  (0.3–2.3%  of 
CD19
+CD3
CD38
dim  cells)  and  con-
sisted of both IgM
+ and IgM
 cells (un-
published  data).  Their  total  frequency 
was >10-fold lower than the frequencies 
of both CD27
+IgM
+ and CD27
+IgM
 
memory B cells in adult blood (Fig. 1 E). 
Therefore, we conclude that CD43
+ B 
lymphocytes constitute a small minority 
of total CD27
+ B lymphocytes.
In conclusion, our results confirm a 
decline with age of the overall popula-
tion of CD27
+CD43
+ circulating hu-
man B cells, but indicate that caution 
should be taken in the definition of hu-
man B1 cells inside this heterogeneous 
cell population. Detailed flow cytomet-
ric analysis of CD19
+CD27
+CD43
+ cells 
reveals that the majority may be CD38
hi 
plasma cells or contaminating CD3
+ T 
cells. The large proportion of T cells in 
our analysis might explain the high fre-
quency of CD5
+ cells reported by Grif-
fin et al. (2011), as all T cells express 
CD5. Finally, we conclude that clearly 
defined  CD3
CD38
dimCD27
+CD43
+ 
B lymphocytes may be only a minor 
population of CD27
+ memory B cells 
in adult blood. Understanding the func-
tional  similarities  between  these  cells 
and mouse B1 cells will be important 
topics for additional studies in regard to 
infectious  diseases  and  lymphoid  ma-
lignancies. However, these studies will 
require the exclusion of T cells and cir-
culating plasma cells from such analysis.
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Griffin et al. respond:
In the January 2011 issue of the JEM, 
we identified a population of B cells in 
human umbilical cord and adult periph-
eral  blood  that  manifests  three  key 
functional  features  of  mouse  B1  cells 
(spontaneous immunoglobulin secretion, 
tonic intracellular signaling, and efficient 
T cell stimulation). This population is 
Human B1 cells are CD3
: A reply to “A human 
equivalent of mouse B-1 cells?” and “The nature  
of circulating CD27
+CD43
+ B cells”JEM Vol. 208, No. 13
Letters
2567
Figure 1.  Human CD20
+CD27
+CD43
+ B1 cells do not express CD3. (A) Adult peripheral blood 
cells were immunofluorescently stained with specific antibodies. CD20
+CD27
+CD43
+ B1 cells were 
sort-purified from nonenriched, as well as CD19-enriched PBMCs and sorted B1 cells were analyzed 
for CD3 expression. Gating was based on an isotype control. Results for one of three comparable 
experiments are shown. (B) Adult peripheral blood cells were immunofluorescently stained, sort-
purified for naive (CD19
+CD27
CD43
/CD20
+CD27
CD43
) and B1 (CD19
+CD27
+CD43
+/
CD20
+CD27
+CD43
+) cells, and examined by confocal microscopy. (C) Immunofluorescently stained 
PBMCs were analyzed at high concentration without vortexing without (top row) or with (bottom 
row) FSC-H/FSC-A doublet discrimination. The last panel shows CD3
+ events among 
CD20
+CD27
+CD43
+ cells. (D) The same sample as in C was diluted and vortexed, and then analyzed 
without (top row) or with (bottom row) FSC-H/FSC-A doublet discrimination. Note that many more 
cells appear as singlets (99.1%) as compared with C (75.9%). The last panel shows CD3
+ events 
among CD20
+CD27
+CD43
+ cells. Results for one of three comparable experiments are shown.  
(E–G) Adult peripheral blood cells were immunofluorescently stained, and then presented for flow 
cytometric analysis at various cell concentrations, as indicated (n = 12). The proportion of single cells 
determined by FSC-H/FSC-A gating is shown as a function of cell concentration in E. The proportion 
of CD3
+ events among gated CD20
+CD27
+ cells is shown as a function of cell concentration in F.  
The proportion of CD3
+ events among gated CD20
+CD27
+CD43
+ cells is shown as a function of cell 
concentration in G. (H) Adult peripheral blood cells were immunofluorescently stained with specific 
antibodies, brought into a single cell suspension, and sort-purified on an Influx (BD) instrument. The 
gating strategy used for experiments reported in Griffin et al. (2011) is shown.
marked  by  the  phenotype  CD20
+ 
CD27
+CD43
+CD70
  (Griffin  et  al., 
2011).  We  appreciate  the  interest   
shown  in  this  work  by  Perez-Andres   
et al. and Descatoire et al., who have 
written letters to report CD3
+ events 
detected  within  CD19
+CD27
+CD43
+ 
and CD20
+CD27
+CD43
+ gated popu-
lations, respectively, during their flow 
cytometry. 
The  problem  of  CD3  positivity 
among “a major fraction” (Perez-Andres 
et al., 2011) and “a large fraction” (Des-
catoire et al. 2011) of CD27
+CD43
+ B 
cells is not something we have expe-
rienced.  In  our  hands,  CD3
+  events 
within  CD20
+CD27
+CD43
+  sort-puri-
fied populations are rare. In early work, 
we  tested  the  function  of  B1  cells 
that  were  sort-purified  from  PBMCs 
without prior enrichment (Griffin et al.,   
2011);  these  CD20
+CD27
+CD43
+ 
populations contain <3% CD3
+ events 
(2.9 ± 0.66%; n = 3). In later work, 
we studied the function of B1 cells that 
were sort-purified from PBMCs after 
enrichment  with  anti-CD19  beads; 
these  CD20
+CD27
+CD43
+  popula-
tions contain <1% CD3
+ events (0.57 
± 0.37%; n = 3; Fig. 1 a). The exis-
tence of CD27
+CD43
+ coexpressing B 
cells seems irrefutable; single cells ex-
pressing CD19, CD27, and CD43, and 
single  cells  expressing  CD20,  CD27, 
and CD43, can be readily visualized as 
confocal microscopic images (Fig. 1 b).
To  discern  the  origin  of  the  re-
ported CD3
+ events, we attempted to 
recreate  the  observations  of  Perez-
Andres et al. (2011) and Descatoire et 
al.  (2011).  We  reproduced  the  high 
frequency  of  double  staining  events 
observed by these investigators only by 
changing  our  usual  protocol  for  cell 
preparation.  When  we  reconstituted 
mononuclear cells at a relatively high 
concentration,  we  observed  CD3
+ 
events  in  the  CD20
+CD27
+CD43
+ 
gate.  FSC-H/FSC-A  discrimination 
decreased,  but  did  not  completely 
eliminate, CD3
+ staining in that gate 
(Fig. 1 c). Diluting and vortexing the 
sample reduced the frequency of CD3
+ 
events  in  the  CD20
+CD27
+CD43
+ 
gate, which was further reduced by ap-
plying  FSC-H/FSC-A  doublet  dis-2568
unique CD27
+CD43
+ B cell popula-
tion that we first reported in January 
(Griffin  et  al.,  2011),  amounting  to   
2–3% of all B cells in Weller’s hands. 
Furthermore,  Perez-Andres  et  al. 
(2011) stated that their results confirm 
a decline with age among CD27
+CD43
+ 
B  cells,  recapitulating  our  published 
results (Griffin et al., 2011). It appears 
that the major issue raised by these two 
letters relates simply to different num-
bers for the frequency of CD27
+CD43
+ 
B1 cells. There are numerous reasons 
why different laboratories might arrive 
at different frequencies, including vari-
ations in sample size, donor age, cell 
preparation, antibody/fluorophore se-
lection, and instrument and run char-
acteristics, not to mention the efficacy 
of  doublet  discrimination.  With  re-
spect to the first two reasons, in our 
January  2011  article  (Griffin  et  al., 
2011), we averaged noncord periph-
eral blood samples to obtain a mean 
CD27
+CD43
+ B cell frequency across 
25 highly variable samples; however, 
many  of  these  samples  were  obtained 
from children, whose B1 cell frequen-
cies are elevated with respect to middle 
aged adults, and we included values that 
would now be considered outliers. In 
our current work with samples from in-
dividuals in the third through seventh de-
cades of life, we obtain values over a wide 
range  (1–9%)  of  CD20
+CD27
+CD43
+ 
B1 cells among all circulating B cells, a 
range recapitulated by other groups, in-
cluding  the  letter  writers.  Our  recent 
identification of human B1 cells provides 
the means to explore the regulation and 
role of this unique population in human 
health and disease. Functional B1 cells in 
the human system phenotype as CD20
+ 
CD27
+CD43
+CD70
 and do not ex-
press CD3.
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tics  of  single  CD20
+CD27
+CD43
+  
B cells.
Descatoire et al. (2011) notes that in 
the  human  system  allogeneic  T  cell 
stimulation has been ascribed to mem-
ory B cells (Good et al., 2009). How-
ever, CD20
+CD27
+ B cells, historically 
considered memory B cells, fail to allo-
geneically  stimulate  T  cells  after  re-
moval of CD43-expressing constituents 
(Griffin  et  al.,  2011).  Furthermore, 
doublets formed by naive B cells and T 
cells would not be expected to manifest 
T cell stimulatory capacity nor would 
their removal be expected to adversely 
affect any memory B cell function. This 
emphasizes  in  another  way,  through 
negative  depletion,  the  existence  of 
functionally distinct, CD43-expressing 
CD27
+ B cells.
Descatoire  et  al.  (2011)  suggests 
that  their  CD3
CD20
+CD27
+CD43
+ 
B cells were either IgD
+ or IgD
; in 
our  hands,  CD20
+CD27
+CD43
+  B1 
cells predominantly expressed IgD, and 
gave  rise  to  amplified  and  rearranged 
IgM sequences as shown in our earlier 
study (Griffin et al., 2011), although we 
identified  IgD
CD20
+CD27
+CD43
+ 
B1  cells  that  may  be  responsible  for 
IgA  produced  by  B1  cells,  as  in  the 
mouse  system  (Baumgarth,  2011). 
Perez-Andres et al. (2011) noted that 
their CD3
CD19
+CD27
+CD43
+ lym-
phocytes  expressed  elevated  levels  of 
CD38  and  were  most  likely  plasma 
cells. CD19 does not exclude plasma-
blasts and plasma cells, as does CD20 
(Jego et al., 2001), which we used to 
identify B cells in our study. Descatoire 
et al. (2011) raised the possibility that 
CD20
+CD27
+CD43
+ B cells might be 
activated cells on their way to plasma 
cell differentiation. We addressed this 
in  our  earlier  work  by  showing  that 
B1 cells do not express elevated levels 
of  activation  antigens,  such  as  CD69 
and CD70, and that culture of B1 cells 
with IL-6 for 5 d did not lead to loss of 
CD20 or acquisition of CD138 (Griffin 
et al., 2011).
Both  Perez-Andres  et  al.  (2011) 
and Descatoire et al. (2011) state that 
after excluding CD3
+ events, they in-
deed  identified  the  phenotypically 
crimination (Fig. 1 d). Over a range of 
cell  concentrations,  we  documented 
an  inverse  correlation  between  cell 
concentration  and  the  proportion  of 
singlets  as  determined  by  FSC-H/
FSC-A,  and  a  direct  correlation  be-
tween  cell  concentration  and  CD3
+ 
events in the CD20
+CD27
+ gate and 
in  the  CD20
+CD27
+CD43
+  B1  cell 
gate (Fig. 1, e and f). These results sug-
gest that CD3
+ events within CD20
+ 
B cell populations result from the for-
mation of B:T doublets.
To evaluate the possible existence of 
CD19
+ T cells, as suggested by Perez-
Andres  et  al.  (2011),  we  examined 
CD27
+CD43
+ B cells by confocal mi-
croscopy and failed to identify single cells 
that express both CD3 and CD19 (un-
published data). We examined B cells by 
integrated flow cytometry/image micros-
copy and again failed to identify single 
cells marked by either CD19 or CD20 in 
combination  with  CD3.  Although  the 
possibility of rare B cells that express CD3 
(Wang et al., 2009) or rare T cells that 
express CD20 (Yokose et al., 2001) can-
not be entirely ruled out, these results in-
dicate that such cells must be exceedingly 
rare. We conclude that CD19
+CD3
+ cells 
observed by Perez-Andres et al. (2011), 
like the CD20
+CD3
+ cells observed by 
Descatoire et al. (2011), represent B:T 
doublets.
In  our    results,  CD20
+CD27
+CD43
+ 
B1 cells are individual single cells by 
post-sort analysis. The gating strategy 
that we have used, and continue to 
use, is displayed in Fig. 1 h. Virtu-
ally  all  (99.9%)  events  fell  within  a 
tight  FSC-H/FSC-A  discrimination 
gate, and virtually all (99.9%) events 
corresponded  to  single  nuclei  after 
DNA  staining  with  Hoechst33342 
when analyzed post-sort (unpublished 
data). In addition, we showed by di-
rect  visualization  of  Hoechst33342-
stained nuclei that single cell–sorted 
CD20
+CD27
+CD43
+ B1 cells depos-
ited  onto  glass  slides  are  individual 
single cells, with not a single doublet 
observed in over 1,000 cells examined 
(unpublished data). Thus, the B1 cell 
functions delineated in our previous 
work  correspond  to  the  characteris-JEM Vol. 208, No. 13
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